Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series

Katherine Given Ligtenberg; Jamie Katy Hu; William Damsky; Kelly Olino; Harriet Kluger; James Clune; Shawn E Cowper; Gauri Panse; Jonathan Leventhal; Sarah A Weiss

doi:10.1016/j.jdcr.2020.05.010

Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series

JAAD Case Rep. 2020 May 17;6(7):628-633. doi: 10.1016/j.jdcr.2020.05.010. eCollection 2020 Jul.

Authors

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
² Yale University School of Medicine, New Haven, Connecticut.
³ Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
⁴ Department of Medicine/Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.
⁵ Department of Plastic and Reconstructive Surgery, Yale University School of Medicine, New Haven, Connecticut.
⁶ Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.

No abstract available

Keywords: BCC, basal cell carcinoma; PD-1, anti–programmed cell death 1; PD-L1, programmed cell death ligand 1; advanced basal cell carcinoma; anti–PD-1; immunotherapy.

Publication types

Case Reports

Publication types

Grants and funding